Advocating on behalf of the deadliest cancers, which are defined by the Recalcitrant Cancer Research Act as those with a five-year relative survival rate below 50 percent.
2026 · 3rd Quarter (July 1 - Sep 30)
NATIONAL BRAIN TUMOR SOCIETY ON BEHALF OF DEADLIEST CANCERS COALITION
Filed by MGD STRATEGIES LLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Aug 12, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- MGD STRATEGIES LLC
- Filing UUID
- f46aae29-837b-48b8-a4b7-a81763cb87e3
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Advocating on behalf of the deadliest cancers, which are defined by the Recalcitrant Cancer Research Act as those with a five-year relative survival rate below 50 percent.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.